# Bioequivalence Trial of Liquid Versus Freeze-Dried Pergoveris® in Pituitary Suppressed Healthy Premenopausal Female Subjects

> **NCT02317809** · PHASE1 · COMPLETED · sponsor: **Merck KGaA, Darmstadt, Germany** · enrollment: 34 (actual)

## Conditions studied

- Healthy

## Interventions

- **DRUG:** Liquid pergoveris
- **DRUG:** Freeze-dried pergoveris

## Key facts

- **NCT ID:** NCT02317809
- **Lead sponsor:** Merck KGaA, Darmstadt, Germany
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2015-01-31
- **Primary completion:** 2015-10-31
- **Final completion:** 2015-10-31
- **Target enrollment:** 34 (ACTUAL)
- **Last updated:** 2018-07-16


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02317809

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02317809, "Bioequivalence Trial of Liquid Versus Freeze-Dried Pergoveris® in Pituitary Suppressed Healthy Premenopausal Female Subjects". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT02317809. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*